According to a recent LinkedIn post from Glooko, the company is featuring its clinical leadership in a March 17 webinar hosted with Becker’s Healthcare focused on inpatient glycemic safety. The session is set to include physicians from NYC Health + Hospitals, Hackensack Meridian Health, and Temple Health, alongside Glooko’s Paul Chidester, M.D.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights that the webinar will address practical strategies to support frontline clinicians, standardize clinical workflows, and align glycemic management with new CMS reporting mandates on severe hypoglycemia and hyperglycemia. For investors, this emphasis on regulatory-aligned glycemic management suggests Glooko is positioning its solutions as enablers of compliance and quality metrics in hospital settings.
By associating with prominent health systems and Becker’s Healthcare, Glooko appears to be reinforcing its credibility in inpatient diabetes care and health I.T. workflows. This may support deeper penetration into enterprise hospital accounts, potentially enhancing recurring revenue opportunities as providers face increasing pressure to meet CMS reporting requirements.
The focus on inpatient glycemic safety indicates a strategic tilt toward complex, high-acuity care environments where clinical and financial stakes are significant. If Glooko’s tools can help hospitals reduce reportable adverse events and improve performance-based reimbursement, the company could strengthen its competitive position within the digital health and diabetes management ecosystem.